Neuroendocrine carcinoma of the digestive tract: A literature review

被引:1
作者
Jacob, J. [1 ]
Chargari, C. [1 ]
Helissey, C. [1 ]
Ferrand, F. -R. [1 ]
Ceccaldi, B. [1 ]
Le Moulec, S. [1 ]
Bauduceau, O. [1 ]
Fayolle, M. [1 ]
Vedrine, L. [1 ]
机构
[1] Hop Instruct Armees Val de Grace, Serv Oncol Radiotherapie, F-75005 Paris, France
来源
REVUE DE MEDECINE INTERNE | 2013年 / 34卷 / 11期
关键词
Neuroendocrine carcinoma; Digestive tract; Chemotherapy; SMALL-CELL CARCINOMA; PHASE-II TRIAL; POSITRON-EMISSION-TOMOGRAPHY; ENDOCRINE TUMORS; ARTERIAL CHEMOEMBOLIZATION; GASTROINTESTINAL-TRACT; PROGNOSTIC-FACTORS; INTERFERON-ALPHA; CHROMOGRANIN-A; CHEMOTHERAPY;
D O I
10.1016/j.revmed.2013.02.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neuroendocrine carcinoma is a rare and agressive malignant tumor, mainly developing at the expense of the respiratory and of the digestive tract. Among the digestive tract, appendix, small bowel, and pancreas are the preferential sites of involvement, other locations have been more rarely reported. Neuroendocrine digestive tumors may present with various symptoms in relationship with their localization and a complex pathophysiology. Diagnosis is often made at an advanced stage, explaining partly the bad prognosis of these tumors. The optimal management of digestive neuroendocrine tumors is rendered difficult by their rarity and by a low number of randomized trials. We review the literature regarding epidemiologic and prognostic features of these rare tumors, their diagnostic and therapeutic care. Potential complications are also discussed. (C) 2013 Societe nationale francaise de medecine interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:700 / 705
页数:6
相关论文
共 63 条
[1]   Hereditary neuroendocrine tumors of the gastroenteropancreatic system [J].
Anlauf, Martin ;
Garbrecht, Nele ;
Bauersfeld, Juliane ;
Schmitt, Anja ;
Henopp, Tobias ;
Komminoth, Paul ;
Heitz, Philipp U. ;
Perren, Aurel ;
Kloeppel, Guenter .
VIRCHOWS ARCHIV, 2007, 451 :S29-S38
[2]   Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours [J].
Baudin, E ;
Gigliotti, A ;
Ducreux, R ;
Ropers, J ;
Comoy, E ;
Sabourin, JC ;
Bidart, JM ;
Cailleux, AF ;
Bonacci, R ;
Ruffié, P ;
Schlumberger, M .
BRITISH JOURNAL OF CANCER, 1998, 78 (08) :1102-1107
[3]  
Baudin E, 2000, ENCY ORPHANET, P1
[4]  
Baudin E, 2008, TUMEURS ENDOCRINES T, P21
[5]   Detection of Neuroendocrine Tumors of the Small Bowel by Double Balloon Enteroscopy [J].
Bellutti, Michael ;
Fry, Lucia C. ;
Schmitt, Johannes ;
Seemann, Marcus ;
Klose, Silke ;
Malfertheiner, Peter ;
Moenkemueller, Klaus .
DIGESTIVE DISEASES AND SCIENCES, 2009, 54 (05) :1050-1058
[6]   18F-Fluorodeoxyglucose Positron Emission Tomography Predicts Survival of Patients with Neuroendocrine Tumors [J].
Binderup, Tina ;
Knigge, Ulrich ;
Loft, Annika ;
Federspiel, Birgitte ;
Kjaer, Andreas .
CLINICAL CANCER RESEARCH, 2010, 16 (03) :978-985
[7]  
Brandi ML, 2001, J CLIN ENDOCR METAB, V86, P56
[8]   Small-cell carcinoma of the gastrointestinal tract: a retrospective study of 64 cases [J].
Brenner, B ;
Shah, MA ;
Gonen, M ;
Klimstra, DS ;
Shia, J ;
Kelsen, DP .
BRITISH JOURNAL OF CANCER, 2004, 90 (09) :1720-1726
[9]  
Cadiot G, 2006, GASTROENTEROL CLIN B, V30
[10]  
Casas F, 1997, CANCER, V80, P1366, DOI 10.1002/(SICI)1097-0142(19971015)80:8<1366::AID-CNCR2>3.3.CO